Comparative effectiveness trial in children with suspected focal cerebral arteriopathy (FCA) that compares the use of early corticosteroid treatment versus delayed/no corticosteroid treatment.
Study Details
Internal Title:
FOcal Cerebral Arteriopathy Steroids (FOCAS) Trial
PCH IRB Number:
S-IRB-23-249
Clinical Trials Government Identifier:
NCT06040255
Diagnoses & Treatments:
Focal Cerebral Arteriopathy, FCA, pediatric stroke, arterial ischemic stroke
Study Type:
Clinical Trial
Eligibility:
Age 1-18 at stroke/TIA ictus, acute AIS or TIA in prior 4 days (96 hours), no other identified cause of stroke/TIA other than FCA
Enrollment Status:
Open
Phase:
IV